Haemanthus reportedly told investors that it had around two dozen advisers, including veterinarians and diagnosticians, though specific names were not provided.

Haemanthus, a blood testing startup from Billy Evans, partner of Elizabeth Holmes, has taken to X to say it's not 'Theranos 2.0.' ...

In a public statement, the company has said Holmes holds no formal role at the startup and insisted Haemanthus was not "Theranos 2.0." Holmes is currently serving an 11-year sentence for ...

Haemanthus’s materials say the long-term goal is to develop a stamp-size, wearable version of the product for humans. “Based on our experience and partner input,” it says, that will require ...

Haemanthus added: "This is not Theranos 2.0." A lawyer for Holmes did not reply to a request for comment. Haemanthus is in its early stages, according to one person with knowledge of the company.

Now her partner, Billy Evans, has founded a company called Haemanthus, which also touts a diagnostic blood-testing device that uses only small amounts of blood. While Elizabeth has no legal ...

Evans’ company is called Haemanthus — named after a flower also known as the blood lily, because of course it is — and bills itself as “the future of diagnostics”, as reported by the New ...

Holmes, serving an 11-year sentence, has no official role in Billy Evans biotech startup Haemanthus. Firm says it's not "Theranos 2.0," experts skeptical.

Haemanthus’s Patent for ‘Raman Spectroscopy System’ May 10, 2025 Share full article ... Download the original document (pdf) ...

What is Haemanthus? Based on information provided to NPR, Haemanthus is a diagnostics company that’s planning to build a tool that can scan biological material like blood, sweat, and urine to ...

Haemanthus is using AI-driven medical diagnostics Haemanthus is still in its early development phase, NPR reported, citing a source familiar with the company, and has mainly raised funds from ...